文献速递骨质疏松与代谢性骨病创伤骨科

骨科环境下骨折联络服务的表现:关键指标报告与纵向结局改善

Performance of a Fracture Liaison Service in an Orthopaedic Setting: A Report of Key Indicators and Improvement of Longitudinal Outcomes.
PubMed 文献 · J Bone Joint Surg Am · 2020-01-01

该研究在2个骨科门诊实施骨折联络服务(FLS),纳入≥40岁近期脆性骨折患者532例(平均63.4岁,85.7%女性),进行2年系统随访。结果显示骨密度检测率88.7%、抗骨质疏松药物处方率86.6%、至少1次随访率83.6%,后续骨折发生率为2.6/100人年,CTX-1下降>35%,功能与疼痛有临床重要改善,但生活质量改善未达临床重要程度。

要点

  • FLS在2个骨科门诊实施,≥40岁脆性骨折患者532例,平均63.4岁,85.7%为女性。
  • 骨密度检测率88.7%,抗骨质疏松药物处方率86.6%,至少1次随访率83.6%。
  • 后续骨折发生率为2.6/100人年(23例骨折),CTX-1平均下降>35%。

核心结论

  • 在该FLS中,2年期间检查、治疗和参与率均>80%,后续脆性骨折发生率<3/100人年,提示强化FLS模型有效,但需随机对照试验支持。

研究设计与样本

  • 在2个骨科门诊实施FLS,招募≥40岁近期脆性骨折的男性和女性,进行2年系统随访,收集临床数据、问卷及行政数据库的医疗服务和住院索赔数据。

主要发现

  • 共招募532例受试者,平均年龄63.4岁,85.7%为女性。
  • 472例(88.7%)收集到骨密度结果,86.6%的患者获得抗骨质疏松药物处方。
  • 83.6%的患者至少参加1次随访。
  • 后续骨折发生率为2.6/100人年(23例骨折)。
  • I型胶原C端肽(CTX-1)平均下降>35%;功能能力评分改善14.4%至63.7%,疼痛评分改善19.3%至35.7%,生活质量评分提高3%至15.2%但未达临床重要程度。

关键数值与推荐

  • 关键绩效指标:检查率88.7%(472/532),治疗率86.6%,至少1次随访率83.6%,后续骨折发生率2.6/100人年(23例骨折)。

临床怎么用

  • 在骨科门诊实施强化FLS模型,对≥40岁脆性骨折患者进行系统评估、治疗和2年纵向随访,可达到较高的检查、治疗和随访参与率。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Many Fracture Liaison Services (FLSs) have been successfully implemented, but very few incorporate systematic longitudinal follow-up. The objective of this study was to report on the performance of such an FLS using key performance indicators and longitudinal clinical outcomes. METHODS: An FLS was implemented in 2 outpatient orthopaedic clinics. Men and women who were ≥40 years of age and had a recent fragility fracture were recruited. Participants were evaluated, treated when appropriate, and systematically followed over a 2-year period. Clinical data including chart review and questionnaires were collected. Medical services and hospitalization claims data were retrieved from administrative databases. The primary outcomes were the following key performance indicators: the numbers of investigated and treated patients, follow-up attendance, and the incidence of subsequent fractures. Secondary outcomes were the changes in bone turnover markers and quality of life, physical capacity, and pain scores between baseline and follow-up visits. RESULTS: A total of 532 subjects with a mean age of 63.4 years were recruited; 85.7% were female. Bone mineral density results were collected for 472 subjects (88.7%) and a prescription for anti-osteoporosis medication was given to 86.6% of patients. Overall, 83.6% of patients attended at least 1 follow-up visit. The subsequent fracture incidence rate was 2.6 per 100 person-years (23 fractures). The mean level of type-I collagen C-telopeptide (CTX-1), a bone resorption marker, decreased >35%. Clinically important improvements of functional capacity scores (by 14.4% to 63.7%) and pain level (by 19.3% to 35.7%) were observed over time; however, the increase in quality-of-life scores was not clinically important (by 3% to 15.2%). CONCLUSIONS: In this FLS, the rates of investigation, treatment, and participation were >80% over a 2-year period. The subsequent fragility fracture incidence rate was <3 per 100 person-years. These results suggest that an intensive FLS model of care, with a systematic longitudinal follow-up, is effective. A randomized controlled trial is needed to support these results. LEVEL OF EVIDENCE: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Senay A, Perreault S, Delisle J, et al. Performance of a Fracture Liaison Service in an Orthopaedic Setting: A Report of Key Indicators and Improvement of Longitudinal Outcomes. J Bone Joint Surg Am. 2020. PMID: 31714470. doi:10.2106/JBJS.19.00185

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。